BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Wen JS, Pan ZW, Yao XD, Liu YQ, Zhu YD. Pristimerin ameliorates spasmolytic polypeptide-expressing metaplasia by modulating Cdkn1c (p57)-mediated glycolytic reprogramming. World J Gastroenterol 2026; 32(10): 113771 [PMID: 41809458 DOI: 10.3748/wjg.v32.i10.113771]
URL: https://www.wjgnet.com/1007-9327/full/v32/i10/113771.htm
Number Citing Articles
1
Jun-Hao Han, Kong-Rui Lu, Min Zhang, Guo-Hua Gong. Pristimerin attenuates spasmolytic polypeptide-expressing metaplasia <i>via</i> p57 (<i>Cdkn1c</i>)-mediated glycolytic reprogramming: A metabolic avenue for gastric cancer preventionWorld Journal of Gastroenterology 2026; 32(32): 118600 doi: 10.3748/wjg.118600
2
Siying Niu, Heyuan Sun, Zijian Wang, Qiuyu Jin, Zhiwen Sun, Dongyang Yu, Yang Zhang. Glycolytic reprogramming in precancerous lesions of gastric cancer progression: pathogenesis and therapeutic potentialFrontiers in Oncology 2026; 16 doi: 10.3389/fonc.2026.1885113